Hojjat Salmasian, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electronic Health Records | 20 | 2024 | 4737 | 1.180 |
Why?
|
Medical Order Entry Systems | 4 | 2021 | 522 | 1.160 |
Why?
|
Decision Support Systems, Clinical | 4 | 2024 | 1161 | 1.040 |
Why?
|
Cross Infection | 6 | 2021 | 1434 | 0.770 |
Why?
|
Electronics | 1 | 2022 | 319 | 0.720 |
Why?
|
Electronic Prescribing | 1 | 2020 | 114 | 0.680 |
Why?
|
Proton Pump Inhibitors | 5 | 2017 | 552 | 0.640 |
Why?
|
Knowledge Bases | 4 | 2015 | 98 | 0.640 |
Why?
|
Photography | 1 | 2020 | 530 | 0.580 |
Why?
|
Medication Errors | 2 | 2020 | 781 | 0.570 |
Why?
|
Risk Adjustment | 1 | 2021 | 601 | 0.560 |
Why?
|
Checklist | 2 | 2020 | 826 | 0.530 |
Why?
|
Documentation | 3 | 2021 | 885 | 0.490 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2019 | 662 | 0.480 |
Why?
|
Disclosure | 1 | 2020 | 738 | 0.470 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2015 | 198 | 0.460 |
Why?
|
Patients | 1 | 2020 | 907 | 0.440 |
Why?
|
Drug Prescriptions | 4 | 2019 | 1673 | 0.440 |
Why?
|
Diagnostic Errors | 1 | 2020 | 1266 | 0.430 |
Why?
|
Medical Errors | 5 | 2023 | 1254 | 0.420 |
Why?
|
Inappropriate Prescribing | 1 | 2014 | 209 | 0.400 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2530 | 0.370 |
Why?
|
Drug Utilization Review | 3 | 2019 | 251 | 0.360 |
Why?
|
Clostridium Infections | 4 | 2020 | 557 | 0.350 |
Why?
|
Natural Language Processing | 3 | 2013 | 1128 | 0.350 |
Why?
|
Family | 1 | 2020 | 3189 | 0.330 |
Why?
|
Quality Improvement | 3 | 2024 | 3835 | 0.310 |
Why?
|
Circle of Willis | 1 | 2008 | 79 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2021 | 3208 | 0.300 |
Why?
|
Leukocyte-Adhesion Deficiency Syndrome | 1 | 2007 | 21 | 0.300 |
Why?
|
Leukemoid Reaction | 1 | 2007 | 18 | 0.300 |
Why?
|
Intubation, Gastrointestinal | 1 | 2009 | 169 | 0.300 |
Why?
|
Urinary Catheterization | 2 | 2019 | 200 | 0.290 |
Why?
|
Review Literature as Topic | 1 | 2009 | 339 | 0.290 |
Why?
|
Physicians | 2 | 2022 | 4583 | 0.280 |
Why?
|
Patient Readmission | 1 | 2021 | 3323 | 0.280 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3088 | 0.250 |
Why?
|
Catheter-Related Infections | 2 | 2019 | 272 | 0.250 |
Why?
|
Esophagectomy | 1 | 2009 | 468 | 0.250 |
Why?
|
Otoscopy | 1 | 2024 | 40 | 0.230 |
Why?
|
Postoperative Care | 1 | 2009 | 1476 | 0.200 |
Why?
|
Humans | 61 | 2024 | 759098 | 0.200 |
Why?
|
Bone Marrow Transplantation | 1 | 2010 | 2689 | 0.200 |
Why?
|
Communication | 3 | 2020 | 3846 | 0.180 |
Why?
|
Adrenal Cortex Hormones | 1 | 2010 | 1875 | 0.180 |
Why?
|
Inpatients | 4 | 2023 | 2580 | 0.180 |
Why?
|
Comorbidity | 2 | 2016 | 10550 | 0.170 |
Why?
|
Emergency Service, Hospital | 5 | 2024 | 7788 | 0.170 |
Why?
|
Toilet Facilities | 1 | 2019 | 26 | 0.170 |
Why?
|
Personnel, Hospital | 1 | 2021 | 285 | 0.170 |
Why?
|
Bacterial Infections | 1 | 2007 | 1403 | 0.170 |
Why?
|
Hospitalization | 5 | 2024 | 10732 | 0.170 |
Why?
|
Resuscitation Orders | 1 | 2021 | 270 | 0.160 |
Why?
|
Anti-Bacterial Agents | 6 | 2020 | 7379 | 0.160 |
Why?
|
Intracranial Aneurysm | 1 | 2008 | 1264 | 0.160 |
Why?
|
Research | 1 | 2007 | 1972 | 0.160 |
Why?
|
Antibiotic Prophylaxis | 2 | 2017 | 640 | 0.150 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2024 | 933 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 250 | 0.150 |
Why?
|
Developing Countries | 2 | 2009 | 2862 | 0.150 |
Why?
|
Education, Medical, Undergraduate | 1 | 2007 | 1065 | 0.150 |
Why?
|
Medical Informatics | 2 | 2022 | 732 | 0.150 |
Why?
|
Patient Identification Systems | 1 | 2017 | 75 | 0.140 |
Why?
|
Medical Records Systems, Computerized | 4 | 2019 | 1192 | 0.140 |
Why?
|
Graft vs Host Disease | 1 | 2010 | 3018 | 0.140 |
Why?
|
Hospice Care | 1 | 2024 | 693 | 0.140 |
Why?
|
Retrospective Studies | 17 | 2024 | 80125 | 0.140 |
Why?
|
New York City | 4 | 2022 | 724 | 0.140 |
Why?
|
Clinical Alarms | 1 | 2017 | 61 | 0.140 |
Why?
|
Beds | 1 | 2016 | 48 | 0.140 |
Why?
|
Systematized Nomenclature of Medicine | 1 | 2015 | 34 | 0.130 |
Why?
|
Catheters, Indwelling | 1 | 2018 | 428 | 0.130 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2018 | 342 | 0.130 |
Why?
|
Ulcer | 1 | 2017 | 205 | 0.130 |
Why?
|
Hospitals | 4 | 2021 | 3929 | 0.130 |
Why?
|
Iran | 2 | 2008 | 733 | 0.120 |
Why?
|
Access to Information | 1 | 2017 | 320 | 0.120 |
Why?
|
Antihypertensive Agents | 1 | 2024 | 2062 | 0.120 |
Why?
|
Patient Admission | 1 | 2021 | 1383 | 0.120 |
Why?
|
Information Storage and Retrieval | 1 | 2019 | 821 | 0.120 |
Why?
|
Hospital Administration | 1 | 2017 | 354 | 0.110 |
Why?
|
Off-Label Use | 1 | 2015 | 184 | 0.110 |
Why?
|
Infection Control | 1 | 2021 | 982 | 0.110 |
Why?
|
Genetic Diseases, Inborn | 1 | 2018 | 601 | 0.110 |
Why?
|
Male | 25 | 2024 | 358602 | 0.110 |
Why?
|
Hypertension | 2 | 2024 | 8582 | 0.110 |
Why?
|
Ambulatory Care | 1 | 2024 | 2775 | 0.110 |
Why?
|
Health Services Misuse | 1 | 2014 | 245 | 0.100 |
Why?
|
Urinary Tract Infections | 1 | 2019 | 816 | 0.100 |
Why?
|
Adverse Drug Reaction Reporting Systems | 2 | 2013 | 488 | 0.100 |
Why?
|
Academic Medical Centers | 5 | 2023 | 2750 | 0.100 |
Why?
|
Middle Aged | 18 | 2024 | 219628 | 0.100 |
Why?
|
Clinical Laboratory Techniques | 1 | 2017 | 749 | 0.100 |
Why?
|
Rhabdomyolysis | 1 | 2013 | 155 | 0.100 |
Why?
|
Female | 25 | 2024 | 390174 | 0.100 |
Why?
|
Aged | 15 | 2024 | 168615 | 0.100 |
Why?
|
Patient Discharge | 2 | 2023 | 3460 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5628 | 0.100 |
Why?
|
Intensive Care Units | 4 | 2018 | 3730 | 0.100 |
Why?
|
Ambulatory Care Facilities | 1 | 2017 | 924 | 0.090 |
Why?
|
PubMed | 1 | 2011 | 128 | 0.090 |
Why?
|
Boston | 2 | 2021 | 9274 | 0.090 |
Why?
|
Quality of Health Care | 2 | 2023 | 4356 | 0.090 |
Why?
|
Pepsinogen C | 1 | 2010 | 6 | 0.090 |
Why?
|
Pepsinogen A | 1 | 2010 | 13 | 0.090 |
Why?
|
Gastrins | 1 | 2010 | 74 | 0.090 |
Why?
|
Gastritis, Atrophic | 1 | 2010 | 31 | 0.090 |
Why?
|
Drug Resistance, Bacterial | 1 | 2017 | 1053 | 0.090 |
Why?
|
Reference Standards | 1 | 2013 | 1002 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2024 | 2267 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2020 | 1806 | 0.080 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5310 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2017 | 1395 | 0.080 |
Why?
|
Decision Making, Organizational | 1 | 2009 | 136 | 0.080 |
Why?
|
Prednisolone | 1 | 2010 | 328 | 0.080 |
Why?
|
New York | 2 | 2024 | 874 | 0.080 |
Why?
|
Adult | 16 | 2024 | 219353 | 0.080 |
Why?
|
Algorithms | 4 | 2018 | 13951 | 0.080 |
Why?
|
Methylprednisolone | 1 | 2010 | 385 | 0.080 |
Why?
|
Odds Ratio | 1 | 2020 | 9712 | 0.080 |
Why?
|
Surgical Wound Infection | 1 | 2017 | 1529 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2012 | 882 | 0.070 |
Why?
|
Renal Dialysis | 1 | 2016 | 1758 | 0.070 |
Why?
|
Databases, Factual | 2 | 2019 | 8001 | 0.070 |
Why?
|
Education | 1 | 2009 | 534 | 0.070 |
Why?
|
Data Mining | 1 | 2011 | 550 | 0.070 |
Why?
|
Helicobacter pylori | 1 | 2010 | 379 | 0.070 |
Why?
|
Diabetes Complications | 1 | 2013 | 1342 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3308 | 0.070 |
Why?
|
Vancomycin | 2 | 2020 | 503 | 0.070 |
Why?
|
Pancreatitis | 1 | 2013 | 1100 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2024 | 58864 | 0.070 |
Why?
|
Young Adult | 7 | 2024 | 58477 | 0.060 |
Why?
|
Respiration, Artificial | 1 | 2016 | 2617 | 0.060 |
Why?
|
Length of Stay | 3 | 2024 | 6452 | 0.060 |
Why?
|
Authorship | 1 | 2008 | 281 | 0.060 |
Why?
|
Diffusion of Innovation | 1 | 2009 | 730 | 0.060 |
Why?
|
Adolescent | 8 | 2024 | 87551 | 0.060 |
Why?
|
Autopsy | 1 | 2008 | 1007 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5875 | 0.060 |
Why?
|
Antibodies, Bacterial | 1 | 2010 | 1469 | 0.060 |
Why?
|
Risk Factors | 6 | 2021 | 74167 | 0.060 |
Why?
|
Editorial Policies | 1 | 2008 | 457 | 0.050 |
Why?
|
Pandemics | 2 | 2020 | 8604 | 0.050 |
Why?
|
Sex Distribution | 1 | 2008 | 2294 | 0.050 |
Why?
|
Incidence | 4 | 2021 | 21344 | 0.050 |
Why?
|
Sepsis | 1 | 2017 | 2593 | 0.050 |
Why?
|
Pilot Projects | 2 | 2012 | 8530 | 0.050 |
Why?
|
Cohort Studies | 3 | 2020 | 41266 | 0.050 |
Why?
|
Age Distribution | 1 | 2008 | 2891 | 0.050 |
Why?
|
Suicide | 1 | 2012 | 1599 | 0.050 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 4668 | 0.050 |
Why?
|
Smoking | 1 | 2018 | 9066 | 0.050 |
Why?
|
Health Care Surveys | 2 | 2019 | 2434 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14648 | 0.050 |
Why?
|
Metronidazole | 1 | 2020 | 231 | 0.040 |
Why?
|
Acute Disease | 1 | 2010 | 7247 | 0.040 |
Why?
|
Child | 5 | 2019 | 79604 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25853 | 0.040 |
Why?
|
Paraplegia | 1 | 2019 | 162 | 0.040 |
Why?
|
Education, Nursing | 1 | 2018 | 79 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 3694 | 0.040 |
Why?
|
Patient Transfer | 1 | 2024 | 775 | 0.040 |
Why?
|
Health Policy | 1 | 2009 | 2674 | 0.040 |
Why?
|
Hospital Information Systems | 1 | 2019 | 396 | 0.030 |
Why?
|
Primary Health Care | 2 | 2024 | 4638 | 0.030 |
Why?
|
Antacids | 1 | 2016 | 94 | 0.030 |
Why?
|
Infant | 2 | 2019 | 35940 | 0.030 |
Why?
|
Family Relations | 1 | 2018 | 318 | 0.030 |
Why?
|
Child, Preschool | 2 | 2019 | 41932 | 0.030 |
Why?
|
Quantitative Trait, Heritable | 1 | 2018 | 540 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21019 | 0.030 |
Why?
|
Chronic Disease | 1 | 2010 | 9245 | 0.030 |
Why?
|
Outpatients | 1 | 2022 | 1601 | 0.030 |
Why?
|
United States | 5 | 2021 | 72238 | 0.030 |
Why?
|
Clinical Competence | 1 | 2009 | 4775 | 0.030 |
Why?
|
Research Design | 1 | 2009 | 6165 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2019 | 26099 | 0.030 |
Why?
|
Rectum | 1 | 2018 | 896 | 0.030 |
Why?
|
Workload | 1 | 2019 | 842 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 10329 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2018 | 559 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2015 | 1384 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12963 | 0.030 |
Why?
|
Terminal Care | 1 | 2024 | 1758 | 0.030 |
Why?
|
Drug Utilization | 1 | 2018 | 1195 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2019 | 1722 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3091 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 2019 | 1498 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2021 | 1757 | 0.020 |
Why?
|
Lipids | 1 | 2022 | 3337 | 0.020 |
Why?
|
Massachusetts | 1 | 2024 | 8788 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4572 | 0.020 |
Why?
|
Age Factors | 2 | 2019 | 18391 | 0.020 |
Why?
|
Medical Records | 1 | 2015 | 1405 | 0.020 |
Why?
|
Nurses | 1 | 2018 | 2466 | 0.020 |
Why?
|
Self Report | 1 | 2019 | 3699 | 0.020 |
Why?
|
Publication Bias | 1 | 2008 | 162 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4037 | 0.020 |
Why?
|
Journal Impact Factor | 1 | 2008 | 156 | 0.020 |
Why?
|
Time Factors | 2 | 2019 | 40083 | 0.020 |
Why?
|
Neutropenia | 1 | 2011 | 885 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2012 | 15262 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10515 | 0.020 |
Why?
|
Risk | 1 | 2016 | 9622 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3364 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 12940 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21992 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12152 | 0.010 |
Why?
|
Suicidal Ideation | 1 | 2012 | 1429 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14439 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12526 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15639 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8465 | 0.010 |
Why?
|
Publishing | 1 | 2008 | 837 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16524 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54190 | 0.010 |
Why?
|
Biopsy | 1 | 2010 | 6770 | 0.010 |
Why?
|
Periodicals as Topic | 1 | 2008 | 1469 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39213 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 24049 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2011 | 11891 | 0.010 |
Why?
|